Varicella Zoster Virus Infection (DBCOND0059021)

Identifiers

Synonyms
Chicken pox / Chicken-pox Illness (Varicella Virus Disease) / Vericella-zoster infection / Varicella (Chickenpox) / Varicella Zoster Infection / Varicella (Chicken Pox) / VZV infection / Varicella-zoster Virus Infection / Chickenpox / Varicella zoster virus infection / Varicella-zoster virus infection (disorder) / Varicella without complication / Varicella [chickenpox] / Varicella (disorder) / Varicella

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Acyclovir
A guanosine analog used to treat herpes simplex, varicella zoster, herpes zoster.
Foscarnet
An antiviral used to treat CMV, HIV, and HSV infections.
Human varicella-zoster immune globulin
A solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.
No drug targets
Loteprednol
A corticosteroid indicated in the treatment of pain and inflammation after cataract surgery.
No drug targets
Plasma protein fraction (human)
A plasma protein solution used to treat coagulation factor deficiencies, reverse anticoagulant effects, and shock from a loss of plasma fluids, and is also used in plasma exchange procedures.
No drug targets
Valaciclovir
An guanine nucleoside antiviral used to treat herpes exacerbations.
Varicella zoster vaccine (live/attenuated)
Zostavax vaccine is indicated for the prevention of herpes zoster (shingles) in immunocompetent adults aged 50 years and older. Varivax vaccine is indicated for active immunization for the prevention of...
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04047979
Systems Biology of Zoster Vaccineprevention2completed
NCT01689285
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovirother1completed
NCT04403139
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccinationbasic_science4recruiting
NCT06409494
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Yearsprevention1recruiting
NCT05532540
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05604911
Herpes Virus Infections in Kidney Transplant PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01682109
Palatability Testing of a New Paediatric Formulation of Valacyclovirother4completed
NCT05664152
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05198570
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04081480
Pharmacokinetics of Valacyclovir Oral Solution in ChildrenotherNot Availableterminated
NCT02570126
A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.prevention3completed
NCT00679796
The Effectiveness of Varicella Vaccination in Children in GermanyNo drug interventionsNot AvailableNot Availablecompleted
NCT02329457
VZV Vaccine for Hematopoietic Stem Cell Transplantationprevention2 / 3completed
NCT02367638
Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adultsprevention1completed
NCT02715752
A Retrospective Chart Review Study of Gene-Eden-VIR/NovirinNo drug interventionsNot AvailableNot Availablecompleted
NCT03509701
Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster VirusNo drug interventionsNot AvailableNot Availableunknown_status
NCT00001054
The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Childrentreatment1withdrawn
NCT00326183
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)prevention4completed
NCT01982409
Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Childrenprevention4unknown_status
NCT05732337
Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.No drug interventionstreatmentNot Availablecompleted
NCT01817270
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccineprevention4completed
NCT00921999
Immune Response to Varicella-Zoster Vaccination and InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT04384016
Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years OldNo drug interventionsprevention4completed
NCT01887496
Varicella-related Hospitalizations in TurkeyNo drug interventionsNot AvailableNot Availablecompleted
NCT00002358
A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZVtreatment3completed
NCT00001125
Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpoxprevention1completed
NCT01815073
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccineprevention4completed
NCT02452229
Review of Human Herpes Viruses in BurnsNo drug interventionsNot AvailableNot Availablecompleted
NCT01684072
Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatinprevention4completed
NCT05084508
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Ageprevention2completed
NCT00000953
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patientstreatment2completed
NCT00002315
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systemstreatment3completed
NCT00156559
MMR and Varicella Vaccine in Premature InfantsNo drug interventionsNot AvailableNot Availablecompleted
NCT00098046
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infectiontreatment3completed